Protective drugs in acute large-dose exposure to organophosphates: A comparison of metoclopramide and tiapride with pralidoxime in rats

Anesthesia and Analgesia

Volumn 100, Issue 2, 2005, Pages 382-386

  Petroianu, Georg A ^a   Hasan, Mohammed Y ^a   Nurulain, Syed M ^a   Arafat, Kholoud ^a   Sheen, Rajan ^a   Saleh, Ayman ^a   Schmitt, Andrea ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; METOCLOPRAMIDE; ORGANOPHOSPHATE; OXIME DERIVATIVE; PARAOXON; PRALIDOXIME; PROFENAMINE; PYRIDOSTIGMINE; TIAPRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ERYTHROCYTE; IN VITRO STUDY; IN VIVO STUDY; INTOXICATION; LONG TERM EXPOSURE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ACETYLCHOLINESTERASE; ANIMALS; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTES; FEMALE; MALE; METOCLOPRAMIDE; ORGANOPHOSPHORUS COMPOUNDS; PARAOXON; PRALIDOXIME COMPOUNDS; RATS; RATS, WISTAR; TIAPRIDE;

EID: 12844274988     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000143349.17443.91     Document Type: Article

References (23)

1. Levine R. Recognized and possible effects of pesticides in humans. In: Hayes WJ, Laws ER, eds. Handbook of pesticide toxicology: general principles. Vol. 1. San Diego: Academic Press, 1991:275-360.
2. Petroianu G, Toomes LM, Petroianu A, et al. Control of blood pressure, heart rate and haematocrit during high-dose intravenous Paraoxon exposure in mini pigs. J Appl Toxicol 1998;18: 293-8.
3. Dawson RM. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994;14:317-31.
4. Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorous nerve agents. J Toxicol Clin Toxicol 2002;40:803-16.
5. Johnson MK, Jacobsen D, Meredith TJ, et al. Evaluation of antidotes for poisoning by organophosphorous pesticides. Emerg Med 2000;12:22-37.
6. Graham SG, Crossley AWA. The characteristics of the inhibition of serum cholinesterase by metoclopramide. Eur J Clin Pharmacol 1995;48:225-8.
7. Chemnitius JM, Haselmeyer KH, Gonska BD, et at. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood. Pharmacol Res 1996;34:65-72.
8. Petroianu G, Arafat K, Kosanovic M, et al. In vitro protection of RBC acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox). J Appl Toxicol 2003;23:447-51.
9. Petroianu G, Kühn F, Thyes C, et al. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon. J Appl Toxicol 2003;23:75-9.
10. Petroianu G, Hassan MY, Kosanovic M, et al. Metoclopramide protection of cholinesterase from paraoxon inhibition. Vet Hum Toxicol 2003;45:251-3.
11. Steele JW, Faulds D, Sorkin EM. Tiapride: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation. Drugs Aging 1993;3:460-78.
12. Worek F, Mast U, Kiderlen D, et al. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 1999;288:73-90.
13. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
14. Van Kämpen EJ, Zijlstra WG. Standardization of hemoglobinometry. II. The hemoglobincyanide method. Clin Chim Acta 1961;6:538-44.
15. Dart RC, Goldfrank LR, Chyka PA, et al. Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann Emerg Med 2000;36:126-32.
16. Geldmacher-von Mallinkrodt M, Urbach HJ, Kittel H, et al. Zur Messung der in vivo und in vitro Reaktivierbarkeit alkylphosphatvergifteter Serumcholinesterase durch 2-PAM und Toxogonin mit verschiedenen Substanzen. Z Klin Chem Klin Biochem 1969;7: 480-5.
17. Pannbacker RG, Oehme FW. Pralidoxime hydrolysis of thiocholine esters. Vet Hum Toxicol 2003;45:39-40.
18. Petroianu GA, Missler A, Zuleger K, et al. Enzyme reactivator treatment in organophosphate exposure: the clinical relevance of thiocholine-esteratic activity of pralidoxime. J Appl Toxicol 2004;24:429-35.
19. Tuovinen K, Kaliste-Korhonen E, Raushel FM, et al. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication. Toxicology 1999; 134:169-78.
20. Heyl WC, Harris LW, Stitcher DL. Effects of carbamates on whole blood cholinesterase activity: chemical protection against soman. Drug Chem Toxicol 1980;3:319-32.
21. Stitcher DL, Harris LW, Heyl WC, et al. Effects of pyridostigmine and cholinolytics on cholinesterase and acetylcholine in soman poisoned rats. Drug Chem Toxicol 1978;1:355-62.
22. Laine-Cessac P, Turcant A, Premel-Cabic A, et al. Inhibition of cholinesterases by histamine 2 receptor antagonist drugs. Res Commun Chem Pathol Pharmacol 1993;79:185-93.
23. Fontaine J, Reuse J. The effects of substituted benzamides on frog rectus abdominis. Eur J Pharmacol 1980;68:55-60.